跳至主要内容
临床试验/EUCTR2011-004621-26-AT
EUCTR2011-004621-26-AT进行中(未招募)1 期

The effect of vitamin D supplementation on immune response following hepatitis B vaccine in incident and prevalent hemodialysis patients with vitamin D deficiency - Devitahep

Medical University Graz0 个研究点开始时间: 2012年5月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - incident and prevalent hemodialysis patients who have previously received no HBV-immunisation
  • - vitamin D3 level below 30 ng/ml
  • - aged >18 years
  • - estimated life expectancy >6 months
  • - written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - estimated life expectancy <6 months
  • - hypercacemia defined as a serrum calcium >2,7 mmol/L
  • - acute infection
  • - chronic diseases known to interfere with vitamin D intake or metabolism (such as inflammatory diseases with granuloma: Mb. Wegener, tuberculosis, sarcoidosis, inflammatory bowel disease)
  • - women in childbearing age

研究者

发起方
Medical University Graz

相似试验